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Abstract
Background: Nutritional strategies can decrease saturated fatty acids (SFAs) and increase health beneficial fatty
acids (FAs) in bovine milk. The pathways/genes involved in these processes are not properly defined. Next-
generation RNA-sequencing was used to investigate the bovine mammary gland transcriptome following
supplemental feeding with 5 % linseed oil (LSO) or 5 % safflower oil (SFO). Holstein cows in mid-lactation were
fed a control diet for 28 days (control period) followed by supplementation with 5 % LSO (12 cows) or 5 % SFO
(12 cows) for 28 days (treatment period). Milk and mammary gland biopsies were sampled on days-14 (control
period), +7 and +28 (treatment period). Milk was used to measure fat(FP)/protein(PP) percentages and individual
FAs while RNA was subjected to sequencing.
Results: Milk FP was decreased by 30.38 % (LSO) or 32.42 % (SFO) while PP was unaffected (LSO) or increased
(SFO). Several beneficial FAs were increased by LSO (C18:1n11t, CLA:10t12c, CLA:9c11t, C20:3n3, C20:5n3, C22:5n3)
and SFO (C18:1n11t, CLA:10t12c , C20:1c11, C20:2, C20:3n3) while several SFAs (C4:0, C6:0, C8:0, C14:0, C16:0, C17:0,
C24:0) were decreased by both treatments (P < 0.05). 1006 (460 up- and 546 down-regulated) and 199 (127 up- and
72 down-regulated) genes were significantly differentially regulated (DE) by LSO and SFO, respectively. Top regulated
genes (≥2 fold change) by both treatments (FBP2, UCP2, TIEG2, ANGPTL4, ALDH1L2) are potential candidate genes for
milk fat traits. Involvement of SCP2, PDK4, NQO1, F2RL1, DBI, CPT1A, CNTFR, CALB1, ACADVL, SPTLC3, PIK3CG, PIGZ,
ADORA2B, TRIB3, HPGD, IGFBP2 and TXN in FA/lipid metabolism in dairy cows is being reported for the first time.
Functional analysis indicated similar and different top enriched functions for DE genes. DE genes were predicted to
significantly decrease synthesis of FA/lipid by both treatments and FA metabolism by LSO. Top canonical pathways
associated with DE genes of both treatments might be involved in lipid/cholesterol metabolism.
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Conclusion: This study shows that rich α-linolenic acid LSO has a greater impact on mammary gland transcriptome by
affecting more genes, pathways and processes as compared to SFO, rich in linoleic acid. Our study suggest that
decrease in milk SFAs was due to down-regulation of genes in the FA/lipid synthesis and lipid metabolism pathways
while increase in PUFAs was due to increased availability of ruminal biohydrogenation metabolites that were up taken
and incorporated into milk or used as substrate for the synthesis of PUFAs.
Keywords: Transcriptome, Mammary gland, Linseed oil, Safflower oil, Fatty acid synthesis, Lipid synthesis, Lipid
metabolism, Canadian Holstein cows
Background
Cow milk provides nutritional benefits to humans and
over the years, intensive efforts have been geared to-
wards increasing milk production as well as its beneficial
components. Growing awareness of the association be-
tween diet and health has driven market demands to-
wards healthier products. Consequently, increasing the
concentration of milk beneficial fatty acids (FAs) with
protective roles against several human diseases including
cancer, cardiovascular diseases, and general health of the
gastrointestinal tract and immunity [1–3] is of great
interest. Several strategies including nutrition and gen-
ome variation are under exploration to achieve increased
milk beneficial components.
Nutritional strategies include feeding high grain/low
forage and feed supplements rich in unsaturated fatty
acids (USFAs) (e.g. soybean oil, corn oil, safflower oil,
linseed oil, canola oil, marine algae, and fish oil) to
dairy animals. These strategies have shown reduced
yields of milk fat and milk saturated fatty acids (SFAs)
of all chain lengths [4, 5]. In particular, FAs synthesized
de novo are decreased to a greater extent, and this re-
sults in a shift in milk FA profile such that the propor-
tion of short and medium-chain FAs are decreased and
longer-chain and USFAs are increased [4, 5]. Thus, milk
fat synthesis under regulation by dietary factors and
feed ingredients high in USFAs cause a phenomenon
known as milk fat depression whereby milk fat yield
can be reduced by up to 50 % while other milk compo-
nents are unaffected [6, 7].
Linseed oil is an attractive supplement in cow’s di-
ets due to its rich content of alpha-linolenic acid
(ALA, C18:3n3), about 50 to 60 % of total fat. Dietary
supplementation of cows’ diets with different forms of
linseed, including linseed oil has resulted to increases
in ALA, conjugated linoleic acid (CLA) and other
omega 3 FAs content of milk [8, 9]. Oil from linoleic
acid (LA) rich safflower (about 76 % of total fat) var-
iety is also used in ruminant diets. Safflower oil sup-
plementation has resulted to increases in the CLA
content of milk in dairy cows [8] and in lean/muscle
tissues of lamb [10, 11]. ALA is a polyunsaturated
fatty acid (PUFA) with three double bonds while LA,
also a PUFA has two double bonds. The different de-
grees of unsaturation of the oils may result in differ-
ent intermediates of biohydrogenation which may
affect differently, the pathways of lipid metabolism.
The profile of ruminal biohydrogenation intermediates
is dependent on the composition of the diet [12] and
both in vivo and in vitro studies have reported the
formation of a wide range of C18:1, C18:2, C18:3 and
CLA intermediates during biohydrogenation [12, 13].
Dietary supplementation of ruminant diets with plant
and fish oils has been shown to affect feed intake and
nutrient digestibility [14, 15]. While addition of 3 %
LSO (on a dry matter basis-DM) to the diets of dairy
cows showed no negative effects [14], Martin et al.
[15] observed decreased dry matter intake and nutri-
ent digestibility following addition of 5.7 % LSO to
the diet. Recently, it was shown that up to 4 % LSO
can be added to the diet of dairy cows without nega-
tive effects [13].
Numerous studies have considered the possible mo-
lecular mechanisms underlying diet-induced changes in
mammary lipogenesis and fat secretion [16–18]. It has
been proposed that intermediates (e.g. trans-10,cis-12-
CLA) from alternative ruminal biohydrogenation path-
ways of USFAs exhibit inhibitory effects on milk fat
synthesis [19–22] and milk yield [6]. Results of investiga-
tions into the molecular basis of nutrient effect on milk
fat content and composition revealed a mechanism of
down regulation of well-established lipogenic genes in
mammary tissue [22–25]. Furthermore, down regulation
of the mRNA abundance of genes encoding enzymes in-
volved in FA transport/uptake, de novo FA synthesis,
desaturation of FA, and triglyceride synthesis has been
associated with milk fat depression [20]. Other studies
have provided further insights into the network of genes
and transcription regulators driving milk fat synthesis
[26–30]. Several transcription factors including sterol
regulatory binding protein 1 (SREBP1) have been impli-
cated in the down regulation of gene expression during
the processes of milk fat depression [22, 31, 32]. How-
ever, these candidate gene approaches consider only a
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few genes at a time thus limiting the breadth of informa-
tion that can be uncovered. One study [30] has used a
global microarray approach to study the transcriptome
response of the bovine mammary gland to diets rich in
USFAs and uncovered 972 differentially regulated genes
between untreated and treated (diets supplemented with
2.7 rapeseed oil, 2.7 soybean oil and 2.7 % linseed oil,
and a 1:1:1 mixture of the three oils) samples of the
same cows and also uncovered several gene pathways
that may be involved. This study [30] informed on the
necessity of using a higher power integrative genomics
strategy with possibility to interrogate the entire tran-
scriptome without restrictions imposed by chip based
assays (e.g. microarray) to better understand the molecu-
lar mechanisms underlying the effect of nutrition on
milk fat synthesis and lipogenesis in general.
The next-generation RNA sequencing technology (RNA-
Seq) allows the whole transcriptome characterization of the
expression of all the genes that are expressed under a given
condition thereby providing deeper knowledge of the tran-
scriptomic events under such conditions. This approach
has been successfully used to study the bovine milk/
mammary tissue transcriptome [33–37] but none of
these studies considered the effect of USFAs on mam-
mary gland transcriptome. In this study, we used RNA-
Seq to gain unprecedented insights into the regulatory
mechanisms underlying nutrient effect on milk fat syn-
thesis and concomitant increase in milk USFAs of
benefit to human health.
Methods
Animals, management and sampling
The study was conducted in the animal facility of the
Dairy and Swine Research and Development Centre,
Agriculture and Agri-Food Canada. Animal care, man-
agement and use procedures were approved by the Ani-
mal Care and Ethics Committee of Agriculture and
Agri-Food Canada, according to the Canadian Council
on Animal Care [38].
Procedures for animal management have been re-
ported in our companion paper on the same animals
[39]. Briefly, twenty-four Canadian Holstein cows, pro-
ducing 35 ± 10 kg of milk per day and in mid lactation
(150 ± 50 days in milk) were used. Animals were
grouped according to number of days in milk and ran-
domly allocated to two treatments in a completely ran-
domized block design. Twenty-four cows were fed a
control diet composed of a total mixed ration of corn
and grass silages (50:50) and concentrates (on dry matter
bases-DM) for 28 days. This was followed by a treatment
period of 28 days during which 12 animals received the
control diet supplemented with 5 % linseed oil (LSO) on
DM basis (LSO treatment) while another group of 12
animals were fed the control diet supplemented with
5 % safflower oil (SFO) on DM basis (SFO treatment).
The FA content of LSO is comprised of 50 to 60 % (g/
100 g) α-linolenic acid (C18:3n-3) while SFO is made up
of about 76 % (g/100 g) linoleic acid (C18:2n6cc). Ingre-
dients and composition of experimental diets are shown
in Additional file 1. Animals were fed individually and
had ad libitum access to water throughout the experi-
ment. Feed intake was monitored daily and body weights
were taken at the end of each period. Milk samples were
collected on day-14 (control period), day+7 (7 days after
onset of treatment), and day+28 (last day of treatment)
for the measurement of test day fat percentage (FP), pro-
tein percentage (PP) and FA profiles. Mammary gland
biopsies (performed on six animals/treatment) were per-
formed as previously described [40] four hours after the
morning milking on day-14, day+7 and day+28. Biopsies
were performed at approximately the same site and same
quarter each time. Tissues were snap frozen in liquid ni-
trogen and stored at −80 °C until used.
Determination of test day fat percentage (FP), protein
percentage (PP) and fatty acid profiles
FP and PP were measured in milk samples with
MilkoScan FT 6000 Series mid-range infrared Fou-
rier transform infrared-based spectrometers (Foss,
Hillerod, Denmark) by Valacta, the Dairy Production
Centre of Expertise for Quebec and the Atlantic
provinces (Valacta Laboratories Inc., Ste-Anne-de-
Bellevue, QC, Canada, www.valacta.com). Individual
FA profiles were determined by gas chromatography
according to O’Fallon et al. [41]. The Hewlett Packard
6890 N gas chromatographic system (Agilent Technology,
Wilmington, DE, USA) equipped with a flame ionization
detector and an auto sampler (Hewlett Packard, Avondale,
PA, USA) and the gas chromatographic capillary column
SLB-IL111 (100 m × 0.25 mm, 0.2 μm in thickness,
Supelco, Bellefonte, PA, USA) were used. Hydrogen was
the gas carrier at 1 mL/min constant flow with linear
velocity of 26 cm/s. Oven temperature was set at 40 °C for
1 min, followed by 80 °C to 170 °C for 1 min, 40 °C to
195 °C for 2 min and 20 °C to 210 °C for 15 min. Injection
port and detector temperatures were set at 250 °C, split
ratio was set to 1:100 and injection volume was 1 μl.
Quantification of FAs was performed with Agilent Tech-
nologies Chemstation vB.04.03 software using the FA
methyl ester standard GLC No. 463 (Nu-Chek Prep Inc.,
Elysian, MN, USA) and C13:0 as the internal standard.
Statistical analysis
Effect of treatments on test day milk FP, PP and indi-
vidual FAs was analyzed with SAS software v9.3 (SAS
Institute Inc., Cary, NC, USA). A completely random-
ized design with repeated measures and mixed effects
ANOVA model (F-test) with Tukey adjustment was
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used. Multiple comparisons were applied to data col-
lected on day-14 (control period), day+7 (7 days after
onset of treatments) and day+28 (last day of treatment).
Data was asymmetrically distributed for some FAs and
was log transformed to fit a normal distribution before
applying the ANOVA model. The least square means of
the log transformed data were back transformed with a
95 % confidence interval for result interpretation.
RNA isolation and sequencing
Total RNA from mammary gland biopsies (50 mg/sample)
were purified using miRNeasy Kit (Qiagen Inc., Toronto,
ON, Canada) according to manufacturer’s instructions,
followed by DNase digestion of genomic DNA with Turbo
DNase Kit (Ambion Inc. Foster City, CA, USA). The
concentration of RNA was measured with Nanodrop ND-
1000 instrument (NanoDrop Technologies, Wilmington,
DE, USA) and the quality was assessed with Agilent 2100
Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA)
using the RNA 6000 Nano Labchip Kit (Agilent Tech-
nologies). All 36 samples had a RNA Integrity Number
value greater than eight.
Libraries were generated from 250 ng of total RNA
using the TruSeq stranded mRNA Sample Preparation
Kit (Illumina Inc. San Diego, CA, USA), as per the man-
ufacturer’s recommendations. Libraries were quantified
using the Quant-iT™ PicoGreen® dsDNA Assay Kit (Life
Technologies, Burlington, ON, Canada) and the Kapa
Illumina GA with the Revised Primers-SYBR Fast
Universal Kit (D-Mark Biosciences, Toronto, ON,
Canada). Average size fragment was determined using a
2100 Bioanalyzer (Agilent Technologies) instrument.
Cluster formation on the flow cell was performed using
the cBot instrument (Illumina Inc,). The 36 libraries
were multiplexed in equal ratios (six/lane) and se-
quenced on six lanes in the form of 50-cycle 100 bp
paired-end reads, on a HiSeq 2000 system (Illumina
Inc.) running HCS software v2.2.58. After sequencing,
demultiplexed FASTQ files were generated by allowing
up to one mismatch in the index. Library preparation
and sequencing were performed by McGill University
and Genome Quebec Innovation Centre (MUGQIC,
http://gqinnovationcenter.com/).
A RNA-Seq analysis pipeline developed by MUGQIC
was used for adaptor trimming, genome mapping, and
transcript assembly. Briefly, trimming and clipping was
done with Trimmomatic software v0.32 [42]. Reads with
a minimum length of 32 nucleotides were aligned to the
UMD3.1 Bos taurus reference genome [43] with TopHat
v2.0.11 and then assembled into transcripts using Cuf-
flinks v2.2.1 with genome annotation gtf file from
Ensembl release 77 [44]. HTSeq-count script from the
HT-Seq software suite [45] was used to generate raw
read counts from the assembled transcripts. The
trimmed mean of Mvalues (TMM) normalization
method was used to normalize read counts data while
reads per kilo base per million mapped reads (RPKM)
was used to establish the transcript expression rate.
EdgeR v3.10 software [46] was used to identify differen-
tially expressed genes [47]. Because a small number of
genes are highly expressed in the mammary gland and
could hamper accurate quantification of lowly expressed
genes, differentially expressed genes were defined signifi-
cant as having a false discovery rate (FDR) with a
Benjamini and Hochberg [48] corrected P value < 0.1 as
recommended [49].
Functional annotation and pathway analyses of
differentially expressed genes
Functional annotation and pathway analyses of differen-
tially expressed genes were performed using Ingenuity
Pathways Analysis (IPA) software, March 2015 release
(http://www.ingenuity.com/, Qiagen, Redwood City, CA,
USA). Within IPA, the ‘Core Analysis’ function was
employed to unlock the biological meaning of genes that
were differentially expressed between treatments and
controls in the context of canonical pathways, disease
and biological functions, and networks.
Real-time qPCR verification of RNA sequencing results
The expression levels of ten genes, including nine differen-
tially expressed (ACE2, FASN, FBP2, MROH2B, RASD1,
SREBF1, TC2N, TIEG2, and UCP2) genes and one highly
expressed gene (CSN2) were analyzed using real-time quan-
titative PCR. qPCR was performed as a validation of RNA
sequencing results. Reverse transcription was performed
with the SuperScript™ II Reverse Transcriptase (Life Tech-
nologies Inc., Burlington, ON, Canada), using aliquots
(1 μg) of the same total RNA used in RNA sequencing ana-
lysis. The cDNA samples were diluted based on the con-
centration of starting RNA to 20 ng/μl. Gene-specific
primers were designed using Integrated DNA Technologies
RealTime qPCR Assay tool (https://www.idtdna.com/sci-
tools/Applications/RealTimePCR/) (Additional file 2). PCR
efficiencies measured for all primer pairs were all within a
range of ±10 %. The PCR reaction mix was composed of
5 μL Power SYBR® Green PCR Master Mix (Life Technolo-
gies Inc., Burlington, ON, Canada), 3 μL cDNA, 300 to 900
nM of each forward and reverse primers (Additional file 2),
and 0.1 U AmpErase® Uracil N-Glycosylase (UNG, Life
Technologies). All real-time PCR reactions were per-
formed using the StepOnePlus™ Real-Time PCR System
(Life Technologies) and the amplifications were done
using the Power SYBR® Green PCR Master Mix (Life
Technologies). The thermal cycling conditions were
composed of a step for UNG treatment at 25 °C for
5 min followed by an initial denaturation/activation
step at 95 °C for 10 min, 40 cycles at 95 °C for 30s, 60 °
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C for 30s and 72 °C for 30s. The experiments were carried
out in triplicate for each data point. The relative quantifi-
cation of gene expression was determined using the 2-ΔΔCt
method [50]. The fold change in gene expression was ob-
tained following normalization to two reference genes,
RPS15 and GAPDH. The two reference genes were found
to be the most stable out of four genes (RPS15, GAPDH,
UXT, and RPS9) tested by Normfinder [51]. A pool of all
the samples was used as inter-plate calibrator.
Results
Effect of treatments on feed intake and body weights of
animals
Weekly feed intake decreased significantly (P < 0.05) dur-
ing dietary supplementation with LSO (49.53 ± 1.28 kg
[week four of treatment]) and SFO (47.89 ± 1.58 kg [week
four of treatment]) as compared to the control period
(55.88 ± 2.04 kg [week two of control period] for LSO and
55.67 ± 2.16 kg [week two of control period] for SFO).
Body weight of animals increased significantly (P = 0.018)
during LSO supplementation (633.67 ± 17.90 kg) as com-
pared to the control period (618.33 ± 15.01 kg) while SFO
supplementation had no significant effect on body weight
of cows (643 ± 6.8 kg [treatment period] as compared to
637.67 ± 4.04 kg [control period]).
Effect of treatments on milk fat/protein percentages, and
individual fatty acid profiles
LSO treatment decreased by 30.38 % milk FP (P <
0.0001) from 3.62 ± 0.15 % (day-14) to 2.52 ± 0.15 %
(day+28) while PP was unaffected, 3.37 ± 0.09 % (day-
14) vs 3.36 ± 0.12 % (day+28) (Table 1). Similarly, SFO
treatment decreased (P < 0.0001) FP by 32.42 % from
3.69 ± 0.09 % (day-14) to 2.50 ± 0.10 % (day+28). In
contrast to LSO treatment, PP was increased (P <
0.0001) by SFO supplementation (3.69 ± 0.09 [day+28]
vs 3.42 ± 0.07 [day-14]) (Table 1).
The proportions of several SFAs (C4:0, C6:0, C8:0,
C14:0, C16:0, C17:0, C24:0 and total SFA) were de-
creased significantly following feeding with both supple-
ments (day-14 vs day+28) while the contents of C12:0
was increased (P < 0.05) by LSO supplementation
(Table 1). Interestingly, the content of C18:0 increased
significantly (P < 0.01) one week after introduction of
supplements as compared to day-14 and decreased
thereafter. While the contents of several MUFAs were
unaffected by treatments, the concentrations of C14:1
and C14:1 t were significantly decreased (P < 0.05) by
LSO supplementation and C14:1 by SFO supplementa-
tion (Table 1). The content of C18:1n11t was increased
(P < 0.05) after 28 days of feeding both supplements and
C20:1c11 by SFO only. The composition of C18:1n9c
was increased by both supplements but significant
increase was recorded following one week of
supplementation with SFO. For PUFAs, the concentra-
tions of CLA:10t12c, CLA:9c11t, C20:3n3, C20:5n3 and
C22:5n3 were significantly (P < 0.05) increased after four
weeks of feeding LSO while CLA:10t12c, C20:2 and
C20:3n3 were significantly increased by SFO (Table 1). In-
creases in C18:2n6cc (LSO and SFO) were only significant
on day+7 as compared to day-14. The proportion of
C18:3n3 increased during supplemental feeding of both
supplements but not significantly. The contents of more
PUFAs were unaffected by SFO (C18:2n6tt, C20:5n3,
C22:5n3, C22:5n6 and C22:6n3) supplementation than by
LSO (C18:2n6tt, C20:2 and C22:5n6) supplementation.
Sequencing, mapping of transcripts and expressed genes
Thirty-six libraries generated on RNA samples from
cows whose diets were supplemented with 5 % SFO or
5 % LSO were sequenced. RNA-sequencing generated a
total of 1,178,749,318 (1.2 billion) raw paired reads with
an average of 33 M reads per library. Alignment of reads
showed that 87.10 % (1,026,544,221) mapped to the bo-
vine genome (UMD3.1.77, has 24,617 annotated genes)
(Additional file 3). Of the mapped reads, 96.40 %
mapped to unique positions, 3.2 % mapped to multiple
positions while 0.38 % were discordant alignments. Only
reads that mapped to unique positions were used in fur-
ther analysis. A total of 18,692 genes were expressed out
of which, 11,151 gene transcripts with more than one
count per million reads in at least 10 libraries [52] were
used in differential gene expression (DE) analysis.
Using percentage of the total number of RPKM values,
genes were classified into very highly (RPKM >2 % of
total RPKM values), highly (0.1 to 1.99 %), medium (0.01
to 0.099 %), lowly (0.001 to 0.0099 %) and very lowly
(<0.0099 %) expressed genes (Table 2). Twenty-four top
expressed genes (very highly and highly expressed genes)
and their functions are listed in Table 3. The expression
of the six main milk protein genes, CSN1S1, CSN1S2,
CSN2, CSN3, LGB and LALBA, and GLYCAM1 was very
high and all together constituted 79.45 % of the total
RPKM values (Additional file 4a). Amongst the very
highly expressed genes, CSN2 and CSN1S1 were the
most expressed with RPKM values of respectively 23.94
and 20.05 % of total. The combined RPKM value of 17
highly expressed genes was 4.79 % of total (Additional
file 4b). Medium expressed genes were about 200 while
the rest, about 18400 were weakly abundant and there-
fore classified as lowly and very lowly expressed genes in
our samples (Table 2).
Effect of supplemental linseed oil (LSO) feeding on
mammary gland transcriptome
During the four weeks of supplementing the feed of
cows with 5 % LSO following a control feeding period
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Table 1 Effect of supplemental feeding with 5 % linseed oil or 5 % safflower oil on test day milk fat percentage, protein percentage and individual fatty acid profiles (g/100 g)
of Canadian Holstein cows
Parameter Linseed oil treatment Overall Safflower oil treatment Overall
Day-14 day+7 day+28 P-value Day-14 day+7 day+28 P-value
Fat percent 3.621c ± 0.146 3.51c ± 0.150 2.521b ± 0.150 0.0001 3.692d ± 0.094 3.423c ± 0.101 2.495b ± 0.100 0.0001
Protein percent 3.367c ± 0.089 3.286b ± 0.091 3.364bc ± 0.121 0.195 3.420c ± 0.074 3.306b ± 0.064 3.685c ± 0.091 0.0001
aFatty acid
eC4:0 2.476 ± 0.244b 0.787 ± 0.244c 0.986 ± 0.244c 0.0000 2.276 ± 0.234b 1.261 ± 0.234c 0.894 ± 0.243c 0.0013
C6:0 1.930 ± 0.200b 1.647 ± 0.200b 0.753 ± 0.200c 0.0003 2.202 ± 0.193b 1.844 ± 0.193b 0.722 ± 0.199c 0.0000
C8:0 0.071 [0.049-0.105]b 0.039 [0.027- 0.058]c 0.020 [0.013-0.031]c 0.0000 0.077 [0.054-0.109]b 0.041 [0.029-0.058]bc 0.028 [0.017-0.048]c 0.0239
C11:0 0.026 [0.012-0.058] 0.024 [0.011-0.053] 0.015 [0.007-0.034] 0.4416 0.037 [0.017-0.077] 0.017 [0.008-0.036] 0.032 [0.014- 0.076] 0.2575
C12:0 0.184 ± 0.362b 1.572 ± 0.362b 1.175 ± 0.362b 0.0037 1.454 ± 0.347 1.408 ± 0.347 1.060 ± 0.361 0.7419
C13:0 0.035[0.019-0.065] 0.029 [0.015-0.054] 0.014 [0.008-0.026] 0.0795 0.051 [0.029-0.092]b 0.022 [0.012-0.039]bc 0.008 [0.005-0.015]c 0.0009
C14:1 t 0.023[0.014- 0.035]b 0.014 [0.009-0.021]bc 0.010 [0.007- 0.016]c 0.0288 0.024 [0.016-0.036] 0.015 [0.010-0.023] 0.013 [0.008-0.020] 0.1071
C14:1 1.166[0.508-2.677]b 0.266 [0.120-0.591]c 0.109 [0.047-0.250]c 0.0009 1.086 [0.504-2.341]b 0.274 [0.127- 0.590]c 0.090 [0.039- 0.205]d 0.0000
C14:0 13.161 ± 1.646b 8.004 ± 1.646c 5.726 ± 1.646c 0.0060 13.626 ± 1.581b 9.572 ± 1.581c 5.900 ± 1.633d 0.0016
C15:0 0.468[0.175-1.250]b 0.025 [0.009-0.066]c 0.018 [0.007-0.049]c 0.0000 0.427 [0.166-1.099]b 0.017 [0.007-0.044]c 0.016 [0.006-0.042]c 0.0001
C16:0 34.439 ± 5.085b 14.653 ± 5.085c 8.502 ± 5.085c 0.0022 31.419 ± 4.886b 13.141 ± 4.886c 15.542 ± 5.082c 0.0301
C17:0 2.809 ± 0.446b 1.643 ± 0.446c 1.157 ± 0.446c 0.0108 2.585 ± 0.428b 1.792 ± 0.428bc 1.018 ± 0.443c 0.0555
C18:0 4.080 ± 1.930c 11.540 ± 1.930b 3.491 ± 1.930c 0.0040 5.430 ± 1.855c 15.916 ± 1.855b 5.967 ± 1.926c 0.0000
C18:1n9t 0.191 ± 0.027bc 0.216 ± 0.027b 0.147 ± 0.027c 0.0132 0.121 ± 0.026 0.200 ± 0.026 0.136 ± 0.027 0.0394
C18:1n9c 10.940 ± 3.450 13.174 ± 3.450 14.442 ± 3.450 0.7999 8.903 ± 3.314c 21.429 ± 3.314b 12.595 ± 3.446bc 0.0025
C18:1n11t 0.023 [0.007-0.074]c 0.160 [0.049-0.519]b 0.175 [0.054-0.567]b 0.0132 0.028 [0.009- 0.088]c 0.087 [0.028-0.269]bc 0.391 [0.121- 1.269]b 0.0074
C18:2n6cc 0.064[0.019-0.215]b 0.186 [0.055-0.626]c 0.051 [0.015-0.172]b 0.0000 0.101 [0.032-0.325]b 0.281 [0.087-0.901]c 0.069 [0.021-0.232]d 0.0000
C18:2n6tt 0.172 [0.094-0.316] 0.018 [0.010-0.031] 0.030 [0.017-0.054] 0.1878 0.219 [0.125-0.383] 0.083 [0.047- 0.145] 0.028 [0.016-0.051] 0.1892
C18:3n3 0.068 [0.025-0.183] 0.164 [0.061-0.442] 0.249 [0.092-0.672] 0.2115 0.070 [0.027-0.181] 0.115 [0.044-0.299] 0.190 [0.070-0.512] 0.2577
CLA:9c11t 0.047 [0.022-0.068]c 0.053 [0.036-0.076]bc 0.069 [0.047-0.100]b 0.3582 0.045 [0.022-0.093] 0.054 [0.026-0.113 ] 0.073 [0.034- 0.156] 0.7682
CLA:10t12c 0.014 [0.008-0.023]c 0.071 [0.044-0.120]b 0.047 [0.030-0.075]b 0.0129 0.020 [0.014-0.029]c 0.034 [0.022-0.053 ]b 0.038 [0.024-0.062]c 0.3535
C20:0 0.013[0.008- 0.021] 0.022 [0.013-0.036] 0.021 [0.013- 0.035] 0.2941 0.014 [0.008-0.022] 0.010 [0.006-0.017] 0.013[0.008- 0.022] 0.5565
C20:1C5 0.067 [0.024-0.183] 0.019 [0.007- 0.051] 0.020 [0.008-0.053] 0.0524 0.061 [0.024- 0.154] 0.038 [0.015- 0.101] 0.014 [0.005-0.036] 0.0880
C20:1C8 0.011 [0.005-0.027] 0.078 [0.033-0.187] 0.104 [0.042-0.258] 0.0053 0.027 [0.012-0.062] 0.008 [0.004-0.019] 0.018 [0.008-0.044] 0.1279
C20:1C11 0.014 [0.008-0.025] 0.030 [0.017- 0.053] 0.027 [0.015-0.048] 0.1911 0.011 [0.006-0.020]c 0.038 [0.022-0.067]b 0.034 [0.019-0.061]b 0.0001
C20:2 0.003 [0.002-0.005] 0.003 [0.002-0.005] 0.003 [0.002-0.005] 0.8993 0.003 [0.002-0.005]c 0.005 [0.003-0.008]b 0.014 [0.008-0.024]b 0.0047
C20:5n3 0.008[0.005-0.013]c 0.016 [0.009- 0.026]bc 0.020 [0.012-0.034]b 0.0144 0.007 [0.004-0.011] 0.006 [0.004-0.010] 0.012 [0.007- 0.021] 0.0895
















Table 1 Effect of supplemental feeding with 5 % linseed oil or 5 % safflower oil on test day milk fat percentage, protein percentage and individual fatty acid profiles (g/100 g)
of Canadian Holstein cows (Continued)
C22:5n3 0.004 [0.002-0.009]c 0.009 [0.005-0.018]bc 0.014 [0.007-0.027]b 0.0507 0.007 [0.004-0.013] 0.006 [0.003-0.011] 0.007 [0.004-0.014] 0.6231
C22:0 0.011[0.008-0.015]b 0.005 [0.004-0.008]c 0.006 [0.004-0.008]c 0.0096 0.009 [0.007- 0.012] 0.008 [0.006-0.011] 0.006 [0.004-0.008] 0.1160
C22:5n6 0.020 [0.013-0.031] 0.011 [0.007-0.017] 0.016 [0.010-0.025] 0.1746 0.011 [0.007-0.016] 0.015 [0.010-0.023] 0.013 [0.008-0.020] 0.4620
C22:6n3 0.038 [0.023-0.064]b 0.019 [0.012-0.029]bc 0.011 [0.007-0.017]c 0.0036 0.028 [0.019-0.042] 0.027 [0.018-0.041] 0.015 [0.009-0.024] 0.1126
C23:0 0.041 [0.009-0.190 ]c 0.168 [0.038-0.739]b 0.044 [0.010-0.194]bc 0.0133 0.053 [0.013- 0.221] 0.110 [0.026-0.455] 0.037 [0.009- 0.163] 0.4339
C24:0 0.028 ± 0.004b 0.014 ± 0.004c 0.019 ± 0.004bc 0.0117 0.030 ± 0.004b 0.023 ± 0.004bc 0.015 ± 0.004c 0.0139
Total SFA 60.743 ± 7.772b 40.580 ± 7.772bc 22.162 ± 7.772c 0.0059 60.974 ± 7.467b 45.653 ± 7.467bc 32.264 ± 7.748c 0.0314
Total MUFA 13.125 ± 3.510 14.189 ± 3.510 15.808 ± 3.510 0.8823 11.429 ± 3.372c 22.300 ± 3.372b 13.556 ± 3.505bc 0.0064
Total PUFA 0.559 [0.327-0.958]c 0.768 [0.449-1.316]bc 1.385 [0.809-2.372]b 0.0049 0.709 [0.423-1.190]c 0.849 [0.730-2.135]bc 1.190 [1.306-3.672]b 0.0124
aThe mean values of C4:0, C6:0, C12:0, C14:0, C16:0, C17:0, C18:0, C18:1n9c, C18:1n9t, C24:0, total SFA (saturated fatty acids) and total MUFA (monounsaturated fatty acids) are represented as MEAN ± SEM, while those
of C8:0, C11:0, C13:0, C14:1, C14:1 t, C15:0, C18:1n11t, C18:2n6cc, C18:2n6tt, C18:3n3, C20:0, C20:3n3, C20:5n3, C22:5n3, C22:5n6, C22:6n3, CLA:10t12c and CLA:9c11t are represented as MEAN (which is back transformed
from the mean of logged mean value) with 95 % confidential intervals. b-dFor each parameter and treatment, means within a row with different superscripts differ significantly (P < 0.05). eResults of the individual fatty

















(no oil added to diet), transcriptome adaptations re-
vealed that a total of 1006 genes were significantly differ-
entially regulated (FDR < 0.1) including 460 up-regulated
and 546 down regulated (Additional file 5a-c). Specific-
ally, comparing gene expression of cows at 7 days (day
+7) after onset of LSO supplementation with the control
period (day-14) indicated that 224 genes were signifi-
cantly up-regulated while 263 genes were significantly
down regulated (Fig. 1a). When the control period (day-
14) was compared with the late treatment period (day
+28), fewer genes were affected, being 79 up-regulated
while 100 were down regulated. Interestingly, the high-
est number of affected genes was seen when the early
treatment period (day+7) was compared with the late
treatment period (day+28), being 203 up- and 251
down-regulated genes. Similar and regulated genes
unique to each pair of comparison are shown in Fig. 1a
and Additional file 5d-e. Most significantly up-
regulated genes with ≥2 fold increase in expression in
at least one comparison period including FBP2,
DMGDH, UCP2, CYP2B6, TRIB3, SESN2, ANGPTL4,
TIEG2, CPT1A, CALB1, ALDH1L2, RNASE1, KLK7 and
IGSF9B are listed in Table 4. Similarly, down regulated
genes with ≥2 fold decrease in expression including M-
SAA3.2, KRT15, CHI3L1, LPIN1, RAB17, MROH2B, SAA
3, CYBRD1, LOXL4, CDH16, ASB11, C28H100R, LOXL4,
LTF, CFI, SDS, NXPE2, FRMPD3 and TMEM132E are
listed in Table 4.
Effect of supplemental safflower oil (SFO) feeding on
mammary gland transcriptome
SFO supplementation of the diets of mid-lactation
cows had less effect on gene expression as compared
to LSO. Results indicate that out of 11,151 genes
compared, 199 genes were significantly differentially
regulated (FDR < 0.1) (127 genes up-regulated and 72
down-regulated) by SFO during the 28 days of dietary
supplementation (Fig. 1b and Additional file 6a-b).
Comparing the different periods, no genes were sig-
nificantly differential expressed between day-14 and
day+7 while 69 genes were significantly up-regulated
and 32 down-regulated when the late treatment
period (day+28, four weeks after onset of treatment)
was compared to the control period (day-14) (Fig. 1b
and Additional file 6a-b). Similarly, 96 genes were up-
regulated and 51 down-regulated when the late treat-
ment period (day+28) was compared with the early
treatment period (day+7) (Additional file 6a-b). Be-
tween these periods, 38 up-regulated and 11 down-
regulated genes were common (Fig. 1b and Additional
file 6c-d). The most significantly regulated gene was
FBP2 (fructose-1,6-bisphosphatase 2) with a 6.3 fold in-
crease in expression between day-14 and day+28. Genes
with ≥ 2 fold changes in expression include FBP2, ACE2,
UCP2, OLRI, ENSBTAG00000016127, SLC17A9, RNASE1
and SCIN (up-regulated) and MROH2B and ISG15
(down-regulated) and are shown in Table 5.
Interestingly, both treatments significantly affected
several genes in the solute-carrier superfamily of genes,
41 by LSO and 5 by SFO (Additional file 7). Whereas
the effect of LSO on mammary gland transcriptome was
more potent than SFO, no differences were observed
when we compared the gene expression on day+7 of
LSO and SFO treatments. The same observation was
made when day+28 was compared. This was surprising
since it was clear from gene expression results that LSO
has a more pronounced effect on the transcriptome than
SFO. We suspected that inter-cow variations could be
responsible. To demonstrate this, we conducted a princi-
pal component analysis on the samples at the different
time points (36 samples) and found out that neither
component 1 and 2 or 2 and 3 could separate the ani-
mals according to treatment (Additional file 8). Instead,
samples from the same animal at the different time
points tended to cluster together. Also, animals were
spread-out hinting at wide inter-animal variations.
Real time qPCR validation of RNA-sequencing results
To validate gene expression results obtained by sequen-
cing, nine DE genes and one highly (but not DE)




Linseed oil treatment Safflower oil treatment
Very highly expressed >2 % 7 7
Highly expressed 0.1 to 1.99 % 15 17
Medium expressed 0.01 to 0.099 % 219 212
Lowly expressed 0.001 to 0.0099 % 2574 2522
bVery lowly expressed, retained <0.0099 % 8508 8393
cVery lowly expressed, not used in DE <0.0099 % 7369 7314
aReads per kilo base per million mapped reads (RPKM)
b,cVery lowly expressed genes had RPKM values of <1 %. Those that had read counts >1CPM (counts per million) in at least 10 libraries were used in differential
gene expression (DE) analysis while those with >1 CPM in less than 10 libraries were not used
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Table 3 Twenty-four top expressed genes and their functions
Gene symbol Gene name a% RPKM
abundance
Gene function
CSN2 Casein beta 23.939 Major milk protein, determine surface properties of casein micelles, source of
bioactive peptides and amino acids, mammary gland specific protein
CSN1S1 Casein alpha s1 20.051 Major milk protein, antioxidant peptide, plays role in the transport of calcium
phosphate, source of bioactive peptides and amino acids, mammary gland
specific protein
LGB (PAEP) Beta-lactoglobulin (progestagen-
associated endometrial protein)
9.993 Major milk protein, play role in retinol binding
CSN1S2 Casein alpha-S2 9.197 Major milk protein, produce casocidin-I that inhibits the growth of bacteria,
plays role in the transport of calcium phosphate, source of bioactive peptides
and amino acids, mammary gland specific protein
CSN3 Casein kappa 8.658 Major milk protein, micelle formation to transport calcium, source of bioactive
peptides (casoplatelin inhibits platelet aggregation, casoxins have opioid
activity) and amino acids, mammary gland specific
LALBA Lactalbumin, alpha- 5.484 Major milk protein, forms regulatory subunit of lactose synthase, enables




2.127 Highly and specifically expressed in the lactating mammary gland, play role in
cell adhesion molecule binding
COX1 Cytochrome c oxidase subunit 1 0.937 Has catalytic activities, is a component of the respiratory chain that catalyzes
the reduction of oxygen to water, subunits 1–3 form the functional core of
the enzyme complex, belongs to the heme-copper respiratory oxidase family
COX3 Cytochrome c oxidase subunit 3 0.509 Has catalytic activity, subunits I, II and III form the functional core of the enzyme
complex, belongs to the cytochrome c oxidase subunit 3 family
ATP6 ATP synthase FO subunit 6 0.430 Play role in the translocation of protons across the membrane, ATPase activity
MT-ND3 Mitochondrially encoded NADH
dehydrogenase 3
0.344 Core subunit of the mitochondrial membrane respiratory chain
NADH dehydrogenase (Complex I), is believed to belong to the minimal assembly
required for catalysis. Complex I functions in the transfer of electrons from NADH
to the respiratory chain
FABP3 Fatty acid binding protein 3,
muscle and heart (mammary-
derived growth inhibitor)
0.2921 Play a role in the intracellular transport of long-chain fatty acids and their
acyl-CoA esters, belongs to calycin superfamily, fatty-acid binding protein family
ND1 NADH-ubiquinone oxidoreductase
chain 1
0.298 Catalytic activity, NADH dehydrogenase activity, belongs to the complex I subunit
1 family
COII (MT-CO2) Mitochondrially encoded
cytochrome c oxidase II
0.301 Is the component of the respiratory chain that catalyzes the reduction of
oxygen to water
MT-ATP8 Mitochondrially encoded ATP
synthase 8
0.252 Unknown function. Is a player in metabolic pathways.
MT-CYB mitochondrially encoded
cytochrome b
0.248 Component of the ubiquinol-cytochrome c reductase complex (complex III or
cytochrome b-c1 complex), a respiratory chain that generates an electrochemical
potential coupled to ATP synthesis (by similarity)
HSTN Histatherin 0.232 Unknown
SPP1 Secreted phosphoprotein 1 0.163 Acts as a cytokine, involved in enhancing production of interferon-gamma
and interleukin-12, reduces production of interleukin-10, is essential in the pathway
that leads to type I immunity, probably involved in cell adhesion, belongs to the
osteopontin family
MT-ND4 Mitochondrially Encoded NADH
Dehydrogenase 4
0.152 Core subunit of the mitochondrial membrane respiratory chain NADH
dehydrogenase (Complex I), is believed to belong to the minimal assembly
required for catalysis. Complex I functions in the transfer ofelectrons from
NADH to the respiratory chain
RPLP1 Ribosomal protein, large, P1 0.144 Is a functional constituent of ribosomes and functions in translational elongation
MFGE8 Milk fat globule-EGF factor 8
protein
0.152 Specific ligand for alpha-v/beta-3 and alpha-v/beta-5 receptors, Contributes to
phagocytic removal of apoptotic cells in many tissues
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expressed gene were selected and quantified by qPCR.
Results are shown in Table 6 and support the differential
expression pattern of genes obtained for both treatments
by RNA-sequencing. Significant differential expression
recorded by RNA-Seq for ACE2, FABP2, CREBF1 and
UPS was confirmed by qPCR. Significant differential ex-
pression of TC2N and TIEG2 by RNA-Seq for LSO was
confirmed by qPCR while their expression tended to-
wards significance (P < 0.090) for SFO treatment by
qPCR method. Expression of FASN by qPCR was signifi-
cant in SFO treatment only. The expression of MROH2B
and RASD1 showed similar down-regulation patterns by
both methods but only significant by RNA-seq method.
FBP2 expression level was highest by both methods of
quantification.
Biological function enrichment and pathway analysis of
DE genes
The effect of dietary SFO or LSO supplements on bio-
logical pathways was studied to identify functions and
pathways that were most affected after four weeks of
feeding diets high in USFAs to cows. Results show that
these genes are enriched in functions related to molecu-
lar/cellular, diseases/disorders and physiological system,
as well as canonical pathways and network functions
(Additional files 9 and 10).
Fig. 1 a-b: Number of commonly and uniquely regulated genes between the different periods of comparison: a Linseed oil treatment and b
Safflower oil treatment
Table 3 Twenty-four top expressed genes and their functions (Continued)
SCD Stearoyl-CoA desaturase (delta-9-
desaturase)
0.133 Catalyzes the insertion of a double bond into a spectrum of fatty acyl-CoA
substrates including palmitoyl-CoA and stearoyl-CoA, belongs to the fatty
acid desaturase family
RNASE1 Ribonuclease, RNase A family, 1 0.099 Nucleic acid binding and ribonuclease A activity
EEF1A1 Eukaryotic translation elongation
factor 1 alpha 1
0.099 promotes the GTP-dependent binding of aminoacyl-tRNA to the A-site of
ribosomes during protein biosynthesis, involved in Th1 (T helper 1) cytokine
production
aRPKM, reads per kilo base per million mapped reads. Values presented as a percentage of all RPKM values
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Table 4 aDifferentially expressed genes with fold change ≥2 in mammary gland of cows fed 5 % linseed oil
bLSO day+7 compared with day-14 LSO day+28 compared with day+7 LSO day+28 compared with day-14
Gene cFC log2FC P-value FDR P-value FC log2FC P-value FDR P-value FC log2FC P-value FDR P-value
ASB11 −3.091 −1.628 1.3E-10 4.9E-07 2.102 1.072 2.2E-05 0.0039 2.102 1.072 2.2E-05 0.0039
DMGDH −2.157 −1.109 0.0037 0.0930 4.359 2.124 6.0E-08 9.6E-05 4.359 2.124 6.0E-08 9.6E-05
ENSBTAG00000034372 −2.477 −1.309 8.4E-06 0.0026 2.000 0.987 0.0007 0.0361 1.982 0.987 0.0007 0.0361
FBP2 3.298 1.721 0.0026 0.0785 3.343 1.741 0.0005 0.0312 3.343 1.741 0.0005 0.0312
ESRP2 −2.000 −0.998 0.0001 0.0139 2.316 1.212 3.2E-06 0.0011 2.316 1.212 3.2E-06 0.0011
FRMPD3 2.198 1.136 4.0E-07 0.0003 −2.550 −1.351 1.8E-09 1.7E-05 −2.550 −1.351 1.8E-09 1.7E-05
IGSF9B 3.032 1.600 0.0010 0.0479 −2.708 −1.437 0.0031 0.0857 −2.708 −1.437 0.0031 0.0857
LTF −2.452 −1.294 1.8E-05 0.0043 2.039 1.028 0.0005 0.0316 2.039 1.028 0.0005 0.0316
SMTNL2 −2.000 −0.969 9.0E-05 0.0128 2.151 1.105 6.1E-06 0.0015 2.151 1.105 6.1E-06 0.0014
RAB17 −2.537 −1.343 0.0005 0.0346 2.311 1.209 0.0017 0.0614 2.311 1.209 0.0017 0.0614
ALDH1L2 - - - - 2.325 1.217 5.6E-06 0.0014 2.325 1.217 5.6E-06 0.0014
ANGPTL4 - - - - 2.834 1.503 2.2E-06 0.0009 2.834 1.503 2.2E-06 0.0009
BEST3 - - - - −2.908 −1.540 3.1E-05 0.0052 −2.908 −1.540 3.1E-05 0.0052
BSP30C - - - - −2.370 −1.245 5.3E-06 0.0014 −2.370 −1.245 5.3E-06 0.0014
C28H10ORF10 - - - - 2.131 1.092 1.3E-06 0.0007 2.131 1.0917 1.3E-06 0.0007
CENPJ - - - - −2.000 −1.000 0.0002 0.0142 −2.000 −1.000 0.0002 0.0142
CLSTN3 - - - - 2.092 1.065 0.0012 0.0518 2.092 1.065 0.0012 0.0518
CYP2B6 - - - - 3.123 1.643 7.8E-08 9.6E-05 3.123 1.643 7.8E-08 9.6E-05
ENSBTAG00000014220 - - - - 2.355 1.236 9.2E-06 0.0020 2.355 1.236 9.2E-06 0.0020
ENSBTAG00000045737 - - - - 3.366 1.751 0.0016 0.0598 3.366 1.751 0.0016 0.0598
FCAMR - - - - 2.081 1.057 0.0003 0.0219 2.081 1.057 0.0003 0.0219
IGFBP2 - - - - 2.155 1.108 0.0019 0.0655 2.155 1.108 0.0019 0.0655
KRT18 - - - - 2.083 1.059 5.6E-06 0.0014 2.083 1.059 5.6E-06 0.0014
NXPE2 - - - - −2.349 −1.232 0.0004 0.0280 −2.349 −1.232 0.0004 0.0280
RNASE1 - - - - 2.021 1.015 0.0024 0.0736 2.021 1.015 0.0024 0.0735
SCN5A - - - - −2.124 −1.087 0.0002 0.0171 −2.124 −1.087 0.0002 0.0171
SESN2 - - - - 2.637 1.399 4.3E-07 0.0003 2.637 1.399 4.3E-07 0.0004
STMN1 - - - - 2.064 1.046 2.1E-06 0.0009 2.064 1.046 2.1E-06 0.0009
TIEG2 - - - - 2.015 1.011 2.8E-07 0.0003 2.015 1.011 2.8E-07 0.0003
TMEM132E - - - - −2.951 −1.561 7.1E-05 0.0082 −2.951 −1.561 7.1E-05 0.0082
TRIB3 - - - - 2.564 1.358 3.8E-07 0.0003 2.564 1.358 3.8E-07 0.0004
UCP2 - - - - 3.153 1.657 7.2E-08 9.6E-05 3.153 1.657 7.2E-08 9.6E-05
ARG2 - - - - −1.951 −0.964 0.0002 0.0155 - - - -
CALB1 2.240 1.164 0.0002 0.0170 - - - - - - - -
CDH16 −2.818 −1.494 3.0E-15 3.4E-11 - - - - - - - -
CDO1 −2.345 −1.230 5.3E-08 7.3E-05 - - - - - - - -
CFB −2.170 −1.118 0.0004 0.0326 - - - - - - - -
CFI −2.454 −1.295 0.0022 0.0737 - - - - - - - -
CHI3L1 −4.095 −2.034 0.0009 0.0455 - - - - - - - -
CYBRD1 −3.310 −1.727 7.4E-06 0.0024 - - - - - - - -
ENSBTAG00000047368 −2.584 −1.370 0.0006 0.0372 - - - - - - - -
ENSBTAG00000048058 −2.239 −1.163 3.6E-07 0.0004 - - - - - - - -
FOS −2.171 −1.118 2.2E-05 0.0049 - - - - - - - -
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Notable amongst enriched molecular and cellular
functions for cows on LSO treatment were cell death
and survival, lipid metabolism, molecular transport,
small molecule biochemistry, protein synthesis, cellular
growth and proliferation and amino acid metabolism
(Fig. 2a). For safflower oil treatment, top cellular and
molecular functions included lipid metabolism, small
molecule biochemistry, energy production, molecular
transport, cellular movement, cell cycle and carbohy-
drate metabolism (Fig. 2b). A striking observation
Table 5 aDifferentially expressed genes with fold change ≥2 in mammary gland of cows fed 5 % safflower oil (on dry matter bases)
bSFO day+28 compared with day-14 SFO day+28 compared with day+7
Genes cFC log2FC P-value FDR P-value FC log2FC P-value FDR P-value
RNASE1 3.664 1.874 2.33E-07 0.0008 3.280 1.713 7.21E-07 0.0018
UCP2 2.362 1.240 1.91E-06 0.0021 2.839 1.505 7.88E-09 8.79E-05
SPADH1 2.104 1.073 1.45E-05 0.0098 2.191 1.132 4.28E-06 0.0037
FBP2 6.302 2.656 2.52E-05 0.0111 4.973 2.314 4.26E-05 0.0127
LBP 2.318 1.213 2.87E-05 0.0122 2.052 1.037 0.0003 0.0437
DPP10 −2.308 −1.207 5.29E-05 0.0177 −2.110 −1.077 0.0004 0.0520
ANGPTL4 2.131 1.091 0.0001 0.0326 2.247 1.168 2.73E-05 0.0092
ACE2 3.061 1.614 1.28E-07 0.0008 - - - -
HPGD 2.159 1.110 1.77E-07 0.0008 - - - -
MROH2B −2.784 −1.477 1.06E-05 0.0084 - - - -
TIEG2 2.115 1.080 1.49E-05 0.0098 - - - -
SCGB1D 2.112 1.079 4.70E-05 0.0168 - - - -
OLR1 3.168 1.664 0.0004 0.0650 - - - -
ALDH1L2 2.001 1.001 0.0004 0.0651 - - - -
ENSBTAG00000016127 - - - - 3.659 1.871 1.29E-06 0.0024
SLC17A9 - - - - 2.543 1.346 4.08E-06 0.0037
MMP19 - - - - 2.206 1.141 1.75E-05 0.0065
ENSBTAG00000000414 - - - - 2.316 1.213 2.09E-05 0.0075
SCIN - - - - 2.510 1.328 2.31E-05 0.0081
IL17RB - - - - 2.217 1.149 4.57E-05 0.0127
STATH - - - - −2.030 −1.022 0.0002 0.0393
ISG15 - - - - −2.676 −1.420 0.0006 0.0640
MX1 −1.964 −0.974 0.0009 0.0843
aOnly genes with fold change values ≥2.00 are shown. Complete list of differentially expressed genes are shown in Additional file 6a-b. No genes were
significantly differentially expressed between day+7 as compared to day-14. bSFO (safflower oil), day-14 (control period), day+7 (7 days of supplemental feeding
with 5 % safflower oil), day+28 (28 days of supplemental feeding with 5 % safflower oil). cFC (Fold change)
Table 4 aDifferentially expressed genes with fold change ≥2 in mammary gland of cows fed 5 % linseed oil (Continued)
H10ORF10 −2.497 −1.320 4.4E-09 1.0E-05 - - - - - - - -
ITGB6 −2.296 −1.199 0.0039 0.0954 - - - - - - - -
KRT15 −4.347 −2.120 5.8E-05 0.0099 - - - - - - - -
LOXL4 −3.087 −1.626 1.4E-08 2.5E-05 - - - - - - - -
MLXIPL −2.125 −1.088 2.0E-06 0.0011 - - - - - - - -
M-SAA3.2 −5.748 −2.523 9.0E-05 0.0128 - - - - - - - -
PRR15L −2.139 −1.097 0.0004 0.0315 - - - - - - - -
SAA3 −3.834 −1.939 5.6E-06 0.0023 - - - - - - - -
SDS −2.355 −1.236 8.9E-05 0.0128 - - - - - - - -
aOnly genes with fold change values ≥2.00 are shown. Complete list of differentially expressed genes are shown in Additional file 5a-c. bLSO- linseed oil, day-14
(control period), day+7 (7 days of supplemental feeding with 5 % linseed oil), day+28 (28 days of supplemental feeding with 5 % linseed oil). cFC (Fold change)
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concerning the affected pathways is the high similarity
between the two treatments. Although a different rank-
ing and involvement of more DE genes in LSO treat-
ment was observed, most of the pathways affected by
LFO were also affected by SFO (Fig. 2).
Within the category of lipid metabolism, several func-
tions were affected (Additional file 11a-b) and also more
genes in LSO treatment (40 genes) were implicated as
compared to SFO treatment (29 genes). Notable were
the effects on concentrations of acylglycerol, triacylglyc-
erol, lipid, FA and eicosanoid, oxidation of lipid and FA,
synthesis of FA and lipid, accumulation of lipid and tri-
acylglycerol, modification of palmitic acid, metabolism
of FA and succinic acid, and conversion of lipid which
according to a negative activation score (z-score) indi-
cates a decrease in activity (Additional file 11a-b). In
particular and considering the expression direction (up-
or down-regulated) of implicated genes (Additional files
12, 13 and 14), IPA analysis predicts significant reduc-
tion of FA synthesis (z-score = −2.710, P-value = 2.0E-
05), lipid synthesis (z-score = −2.281, P-value = 2.9E-04),
and FA metabolism (z-score = −2.212, P-value = 1.1E-04)
following supplemental feeding with LSO (Fig. 3a), and
synthesis of FA (z-score = −2.269, P-value = 3.9E-08) and
lipid (z-score = −2.371, P-value = 4.3E-05) following sup-
plemental feeding with SFO (Fig. 3b). Whereas gene
expression showed a negative z-score (−1.960, P-value =
1.17E-05) for FA metabolism in SFO treatment, de-
creased activation was not predicted by IPA. The net-
work of interactions (Fig. 3a-b) shows how three key
transcription factors, SREBF1, STAT5A and STAT5B re-
late with other molecules, notably FASN, F2RL1, CNT
FR, CALB1, ACSS4, ACADVL and TRIB3 to downregu-
late the synthesis of FA, lipid and FA metabolism. Fur-
thermore, effects of several DE genes (SREBF1, SCNN
1A, INSIG1, DB1 TYK2, CLDN7, SORT1, SCP2, ANGP
TL4, SLC6A4 and KCNMA1) on the concentration of
cholesterol and quantity of steroid with a positive z-
score indicate activation, though not predicted by IPA
(Fig. 4). Cell death and survival were the top molecular
and cellular functions involving 65 differentially
expressed genes in cows fed 5 % LSO for 28 days as
compared to the same cows on the control diet. Sub cat-
egories most affected were cell death (63 genes, P-value












CSN2 1.011 −1.410 −1.397 0.3644 −1.003 0.9856 0.9956
ACE2 1.021 1.915** 1.955 0.0450 2.006** 1.85E-05 0.0050
FASN −1.156 −1.167 −1.348 0.5653 −1.520* 0.0010 0.0740
FBP2 3.921** 3.248** 12.735** 0.0012 11.023** 1.95E-09 4.33E-06
MROH2B −1.957 −1.506 −2.950 0.4434 −4.154** 0.0002 0.0229
RASD1 −1.376 −1.284 −1.767 0.2045 −1.719** 0.0004 0.0472
SREBF1 −1.934* −1.080 −2.088** 0.0297 −1.645** 7.36E-07 0.0005
TC2N 1.124 1.998* 2.246** 0.0358 2.272** 1.82E-06 0.0009
TIEG2 1.069 2.382** 2.546** 0.0070 2.591** 8.01E-12 4.45E-08
UCP2 1.065 2.807** 2.989** 0.0019 2.256** 0.0002 0.0228
Safflower oil treatment
CSN2 −1.233 −1.048 −1.292 0.5687 −1.003 0.9856 0.9956
ACE2 1.830* 1.551 2.838** 0.0241 3.061** 1.28E-07 0.0008
FASN −1.420** −1.318** −1.873** 0.0020 −1.625* 0.0006 0.0854
FBP2 3.583* 3.980* 14.261** 0.0059 6.302** 2.52E-05 0.0111
MROH2B −1.634 −1.972 −3.215* 0.1064 −2.784** 1.06E-05 0.0083
RASD1 1.162 −1.495 −1.287 0.1605 −1.878** 1.71E-06 0.0020
SREBF1 −1.859 −1.420 −2.646** 0.0123 −1.937** 4.62E-06 0.0042
TC2N 1.219 1.831 2.232* 0.0584 1.852* 0.0007 0.0946
TIEG2 1.187 1.547 1.837* 0.0903 2.114** 1.49E-05 0.0097
UCP2 1.002 1.948** 1.952 0.0475 2.362** 1.91E-06 0.0021
*FDR/P-value < 0.1 **FDR/P-value < 0.05
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8.06E-08), apoptosis (48 genes, P-value 1.93E-05), necro-
sis (44 genes, P-value 3.48E-05) and cell survival (22
genes, P-value 3.91E-03) (Fig. 5, and Additional file 15).
Several genes were predicted to decrease cell death
and apoptosis based on their expression direction
(Additional files 16 and 17).
Top canonical pathways that were significantly
enriched by both treatments when day-14 was compared
with day+28 included oncostatin M signaling, IL-22
signaling and role of JAK family kinases in IL-6-type
cytokine signaling while two pathways each were unique
to LSO (TR/RXR Activation, unfolded protein response)
and SFO (role of JAK2 in hormone-like cytokine signal-
ing, antioxidant action of vitamin C) treatments (Table 7,
Additional files 9 and 10). When comparing day+7 with
day+28, only one pathway, LXR/RXR activation, was
common to both treatments while four pathways were
unique to each treatment (Table 7, Additional files 9 and
10). In line with results of DE genes, several top
canonical pathways including UDP-N-acetyl-D-glu-
cosamine Biosynthesis II and UDP-N-acetyl-D-galact-
osamine biosynthesis II were un-regulated only in
LSO treatment when day-14 and day+7 were com-
pared (Table 7, Additional file 9).
Overall, the top networks that were significantly
enriched after 28 days of feeding USFAs to cows as com-
pared to the control period (same cows) were lipid me-
tabolism, small molecule biochemistry, cell morphology,
cellular function and maintenance, cell-to-cell signaling
and interaction, cellular growth and proliferation, post-
translational modifications, metabolic disease, protein
synthesis and carbohydrate metabolism (Additional files
9 and 10). The relationships between DE genes in the
network of genes implicated in lipid metabolism/small
molecule biochemistry/molecular transport are shown in
Additional file 18.
Discussion
In this study, next-generation RNA sequencing technol-
ogy was used to reflect a biological system’s repertoire of
RNA molecules in the bovine mammary gland following
dietary supplementation with 5 % LSO or 5 % SFO. Data
from the control and treated periods were all drawn
from the same animals giving the opportunity to meas-
ure the effect of treatments on gene expression without
the influence of different genetic components. Further-
more, experimental animals were all in the same stage
of lactation (mid-lactation) and sampled within a short
period implying that changes in gene expression due
to a change from one stage of lactation to another was
not expected to influence gene expression results in
this study.
Supplementation of cow’s diets with USFAs decreased
feed intake significantly but body weights increased (P <
0.05) (LSO) or were not affected (SFO) implying that there
was enough energy from supplemental oils to support ani-
mal’s growth. Our data are supported by previous observa-
tions [14, 15]. Although a study found no effect of
Fig. 2 Differentially expressed genes in the mammary glands of cows on supplemental feeding with 5%linseed oil (a) or 5 % safflower oil (b) are
significantly enriched in several molecular and cellular functions
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addition of up to 4 % LSO to the diets of dairy cows on
feed intake [13], our data suggest that addition of 5 %
LSO or 5 % SFO affected palatability of feed and conse-
quently feed intake, which was more apparent during the
first week of supplementation. Similarly, four weeks of
dietary supplementation of cow diets with 5 % LSO or
5 % LSO decreased milk FP by 30.38 % (LSO) or
32.21 % (SFO), which supports earlier investigations
[6, 24, 53–58]. These reductions are confirmed with
the observed significant reductions in the concentra-
tions of majority of SFAs measured. For example, the
concentration of C16:0, one of the most abundant
SFAs in cow milk decreased by 50 % (LSO) or 53 %
(SFO) at the end of supplementation. Our data thus
confirm the effectiveness of LSO and SFO to increase
the concentrations of healthy FAs in milk while de-
creasing SFAs.
Previous studies have shown that the number of genes
expressed in the bovine mammary gland increases with
increasing days in lactation, with the highest at peak lac-
tation followed by gradual decline with increasing days
in lactation [33]. The number of genes expressed at mi-
lactation and pattern of highly expressed genes in this
study reflects previous information [33, 36] and validates
RNA-Seq as a valuable tool in the study of mammary
gland biology. The genes of the main proteins in milk,
CSN1S1, CSN1S2, CSN2, CSN3, LGB and LALBA, as
expected were highly expressed thus concurring with the
abundance of these proteins in milk and with a previous
study [33]. Furthermore, the expression of these genes
were not affected by treatments which supports the ob-
served lack of significant effects of LSO on test-day PP
and agrees with previous investigations [34, 59]. GLY-
CAM1 detected as highly expressed was also reported
amongst highly expressed genes at day 15 of lactation
[33]. GLYCAM1 codes for a milk fat globule membrane
protein and is a member of the mucin gene family. Some
of the top expressed genes (Table 3) have functions re-
lated with milk fat synthesis/uptake (FABP3, SCD) and
mammary gland health (SPP1, MFGE8 and EEF1A1).
The PUFA content was increased significantly in the
milk of treated cows, more so by LS0 (147.76 %) than by
SFO (67.84 %). Milk FAs arise from de novo synthesis in
the mammary gland or are taken up from circulation
(~50:50) [5]. In this study, genes with roles in the syn-
thesis of long chain PUFAs, like FADS1, FADS2, FADS3,
were not affected by treatments suggesting that treat-
ments increased the availability of PUFAs that were up
taken from circulation into milk. Furthermore, LSO (rich
in α-linolenic acid with three double bonds) and SFO
(rich in linoleic acid with two double bonds) appeared to
have affected the biohydrogenation process and associ-
ated pathways differently leading to ruminal outflow of a
wide range of biohydrogenation metabolites that were
Fig. 3 Interaction between differentially expressed genes predicted by IPA to significantly decrease synthesis of fatty acid (z-score =−2.70, P-value = 2.0E-
05), synthesis of lipid (z-score =−2.281, P-value = 2.9E-04) and fatty acid metabolism (z-score =−2.212, P-value = 1.1E-04) in linseed oil treatment (a) and
synthesis of fatty acid (z-score =−2.269, P-value = 3.9E-08) and lipid (z-score =−2.371, P-value = 4.3E-05, P-value = 1.17E-05) in safflower oil treatment (b).
Activity of genes showed a negative z-score (−1.960) for fatty acid metabolism in safflower oil treatment but a decrease was not predicted by IPA
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eventually absorbed and incorporated into milk. Further-
more, these metabolites, especially those resulting from
biohydrogenation of LSO could have affected more path-
ways and also with greater intensity (Fig. 2, Additional
files 9, 10) and could explain the higher number of DE
genes by LSO. It is known that the composition of the
diet affect ruminal biohydrogenation pathways in a
dynamic way leading to the production of a wide range
of positional and geometric isomers and modified FAs
including CLA:10c12c and a multitude of non-
conjugated and partially conjugated C18:2 and C18:3
isomers [12, 13, 60, 61]. It was demonstrated that
feeding dairy cows with increasing levels (2, 3 or 4 %)
of inclusion of linseed oil resulted in a linear increase
in the proportions of several intermediates of ruminal
biohydrogenation products of PUFAs, like C18:1 t10,
C18:1 t11 (trans vaccenic acid), C18:2c9t11 (CLA),
C18:2t11c15 and C18:3c9t11c15 [13]. In this study, the
concentrations of C18:1n11t and CLA:10t12c were signifi-
cantly increased by both treatments and CLA:9c11t by
LSO only. It has been demonstrated that a great propor-
tion of milk CLA:9c11t is produced endogenously in the
mammary gland using rumen produced C18:1 t11 as a
substrate [62]. It is also likely that, other intermediates
were also further desaturated to long chain PUFAs in the
mammary gland. Our data suggest that increased milk
PUFA content during supplemental feeding with LSO and
SFO was due to (1) increased availability of biohydrogena-
tion metabolites (mostly PUFAs) that were up taken and
incorporated into milk and (2) increased availability of FA
metabolites that were further desaturated to longer chain
PUFAs in the mammary gland.
On the other hand, total SFA was decreased by
63.52 % (LSO) or 47.09 % (SFO) after four weeks of sup-
plementation. Individual SFAs most affected were short
and medium chain FAs, which are those FAs mostly syn-
thesized de novo. Several genes known to play roles in
de novo FA synthesis, including SREBF1 (sterol regula-
tory element binding factor1), FASN (fatty acid syn-
thase), ACSS1 (acetyl-CoA short chain synthetase1) and
potential new players (Fig. 3) were significantly down
regulated by treatments in this study. Activation of FA
and cholesterol metabolic pathways requires the coordi-
nated regulation of a network of genes involved in de
novo FA synthesis such as FASN and ACACA (acetyl-
CoA carboxylase alpha) (down regulated in this study
but not significantly), and fatty acid desaturation such as
SCD1 (stearoyl-CoA desaturase 1) (down regulated in
this study but not significantly). It has been noted that
SREBF1 (SREBP1) affects the mRNA expression levels of
Fig. 4 Interaction between differentially expressed genes in (a) linseed oil treatment (LSO) and (b) safflower oil treatment (SFO) showing
increased activity in the concentration of cholesterol (z-score = 1.076, P-value = 7.68E-03 for LSO and 1.135 for SFO, P-value = 4.50E-03) and
quantity of steroid (z-score = 1.428, P-value = 9.47E-03 for LSO and 1.129, P-value = 1.59E-03 for SFO)
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ACACA, FASN, and SCD genes in relation to changes in
triglyceride content and lipid droplet accumulation in
mammary gland epithelial cells in vitro thus supporting
its regulation of FA synthesis [63]. In dairy cows, sup-
port for a central role for SREBP1 in the regulation of
mammary lipid synthesis during milk fat depression with
CLA isomers has been demonstrated [23]. Decreased ex-
pression of SREBF1 gene in this study correlated with
decreased (LSO: FASN, LPIN1, DBI, ACSS1, ADORA2B,
SPTLC3, F2RL1, INSIG1 and STAT5A and B) or in-
creased (LSO: SCP2, PDK4, NQO1, CPT1A, CNTFR,
CALB1, ACADVL, PIK3CG, PIGZ, TRIB3) expression of
genes involved in the synthesis of FAs/lipids and FA me-
tabolism (Fig. 3). Increased/reduced expression of some of
these genes or their protein products have been shown to
be involved in the synthesis of lipid/FAs or FA metabolism
in rodents, humans and ruminants [64–67] (Additional files
12–14). INSIG 1 and 2 are known to alter rates of lipogen-
esis by interacting with SCAP (SREBP cleavage activating
protein) to regulate the sensitivity of SREBP1 and 2 pro-
cessing via SCAP [68, 69]. Involvement of STAT5A and 5B
in FA metabolism and synthesis of lipid/FA has been dem-
onstrated in mice [64, 70] and polymorphisms in these
genes have been associated with milk production traits in
cattle [71–73]. In cows with low fat percentages, it was ob-
served that the mRNA expression level of TRIB3 was
higher than in cows with higher fat percentages [34]. Fur-
thermore, TRIB3 is located in reported QTL regions for
milk FP and PP [74, 75]. It should be noted that more of
these genes were regulated by LSO as compared to SFO.
Our data therefore support roles for SREBF1and these
genes (Fig. 3) in the down regulation of FA/lipid synthesis.
Furthermore, the implication of most of these genes (LSO:
SCP2, PDK4, NQO1, F2RL1, DBI, CPT1A, CNTFR, CALB1,
ACADVL, SPTLC3, PIK3CG, PIGZ, ADORA2B and TRIB3.
SFO: SCP2, PDK4, HPGD, ACADVL, IGFBP2 and TXN) in
the regulation of FA/lipid synthesis and FA metabolism is
being reported in bovine for the first time. Our data there-
fore suggest that decrease in SFAs in this study was mainly
due to down-regulation of genes in the FA/lipid synthesis
and lipid metabolism pathways. Similarly and supported by
previous reports in humans and rodent models [66, 76–79],
Fig. 5 Interaction between differentially expressed genes implicated in apoptosis, necrosis, cell death and survival in cows whose diets were
supplemented with 5 % linseed oil for 28 days as compared to the same cows on the control diet
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decreased expression of SREBF1and regulation of other
genes by USFAs in this study related with increased con-
centration of cholesterol and quantity of lipid (Fig. 4).
Our data show a greater impact of LSO on mammary
gland transcriptome than SFO. However, there were no
significant differences in gene expression between treat-
ments mainly due to inter-cow variations. This observa-
tion supports earlier findings in cows [30] and goats [80]
fed diets supplemented with different USFA rich ingredi-
ents (rapeseed oil, soybean oil, linseed oil and sunflower
oil). Furthermore, our data show that more genes were
significantly differentially regulated by LSO than by SFO
supported by miRNA data on the same animals that
showed a differential regulation pattern of miRNA ex-
pression by LSO and SFO [39].
Genes significantly regulated (≥2 fold change) by both
LSO and SFO could be important candidates in shared
pathways of mammary lipogenesis/FA uptake like FBP2,
UCP2, TIEG2, ANGPTL4 and ALDH1L2. Similarly,
genes significantly regulated with ≥2 fold change by ei-
ther LSO (e.g. DMGDH, CY2B6, TRIB3, SESN2, BEST3,
TMEM132E, etc.) or SFO (e.g. ACE2, OLR1, MROH2B,
etc.) could have biological significance in the specific
pathways up-regulated by either of the oils. FBP2, the
most significantly regulated gene in this study, is a regu-
latory enzyme in gluconeogenesis [81]. In a transgenic
mouse model, overexpression of FBP2 in the liver re-
sulted to lean body weight mostly by reducing adiposity
levels by about 50 % and that reductions in food intake
and not higher energy expenditure were found to be the
contributing factors [82]. FBP2 protein expression is up-
regulated in the liver of rats on a high fat diet [83].
Therefore, FBP2 may be involved in the regulation of
lipogenesis when there is increased presence of FAs in
circulation or when nutrient availability is reduced due
to reduced feed intake. Mitochondrial uncoupling
Table 7 aTop canonical pathways up-regulated by differentially expressed genes in mammary glands of cows whose diets were




Linseed oil treatment Safflower oil treatment
Top Canonical pathways P-value FDR BH
P-value






4.75E-03 - - -
UDP-N-acetyl-D-glucosamine Biosynthesis II 1.94
E-04
3.63E-02 - - -
UDP-N-acetyl-D-galactosamine Biosynthesis II 7.75
E-04
8.68E-02 - - -
Unfolded protein response 1.08
E-03
8.68E-02 - - -
Antigen Presentation Pathway 1.16
E-03
8.68E-02 - - -
Day+7 vs
day+28
Role of Tissue Factor in Cancer 7.81
E-05










Arginine Degradation I (Arginase Pathway) 2.37
E-03




Growth Hormone Signaling 2.67
E-03












Oncostatin M Signaling 1.18
E-04




























Unfolded protein response 7.16
E-04




aTop canonical pathways were the first five enriched pathways with unadjusted P-values <0.002. bHighlighted pathways are common between linseed oil and
safflower oil treatments
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protein 2 (UCP2) and 3, members of the larger family of
mitochondrial anion carrier proteins have been impli-
cated in several human health conditions including
thermogenesis, obesity, diabetes and heart failure [84].
The mRNA levels of UCPs have been reported to be in-
creased by the presence of long-chain FAs [85, 86]. Our
data support these findings [85, 86] and suggest an es-
sential role for UCP2 in mammary lipogenesis and lipid
metabolism in cattle. Kruppel-like factor 11 (KLF11 or
TIEG2) is a zinc finger transcription factor that has been
implicated in the regulation of complex metabolic dis-
eases [87]. The liver and adipose tissues have been iden-
tified as key sources of ANGPTL4 (angiopoietin-like 4),
an adipokine associated with the regulation of lipid
metabolism in cattle [88]. Its expression was found to
change with altered energy balance in lactating dairy cat-
tle [89]. In this study, the up-regulation of ANGPTL4 is
predicted to increase concentration of cholesterol and
quantity of steroid. It was shown in transgenic mice that
ANGPTL3 and ANGPTL4 regulated circulating triglycer-
ide levels under different nutritional regimes and thus
play roles in lipid metabolism through differential inhib-
ition of lipoprotein lipase [77]. ALDH1L2 (aldehyde
dehydrogenase 1 family, member L2) is a member of the
aldehyde dehydrogenase superfamily and the formyl
transferase superfamily and is known to have enzymatic
properties [90]. UCP2 and ANGPTL4 also have roles in
cell growth and apoptosis and their expression direction
were predicted to activate cell death/apoptosis and cell
survival in this study (Fig. 5). Taken together, these re-
ports and our data support major roles for these genes
(FBP2, UCP2, TIEG2, ANGPTL4 and ALDH1L2) in bo-
vine mammary lipid synthesis/metabolism, cell growth
and survival and mammary gland biology. These genes
may therefore be potential markers of milk fat synthesis/
uptake from circulation.
Mammary specific serum amyloid A3 (M-SAA3),
SAA3 and TRIB3 (tribbles pseudokinase 3) (Additional
file 5) were significantly down-regulated by LSO in this
study and are amongst genes proposed as candidates for
milk protein and fat concentrations in dairy cattle [34].
SAA3 has been implicated in lipid metabolism, choles-
terol transport, and in host defence [91, 92]. The expres-
sion of several members of the solute carrier supper
gene family was altered by dietary supplements in this
study, more so by LSO than SFO (Additional file 7). The
solute carrier superfamily encodes membrane bound
transporters responsible for transporting substrates in-
cluding carboxylate, acetyl coenzyme A, vitamins, FAs,
lipids and urea across membranes [34]. Since test day FP
was decreased by treatments in this study, down-
regulation of several of these transporter genes suggest
decreased activity of their protein products in transport-
ing FA components and other materials into the
mammary gland. Further investigations are needed to
clarify this point.
The effect of LSO and SFO on the mammary gland
transcriptome resulted in DE genes being enriched in a
range of networks, molecular and metabolic pathways
related with lipid metabolism, cell death and survival,
transport and cellular function and maintenance, which
supports findings of a number of studies on bovine milk
and mammary tissue transcriptomes under varying lac-
tation conditions [30, 33–35, 37]. Our data further con-
firm results of miRNA analysis on the same animals that
showed target gene enrichment in similar pathways and
gene networks [39]. In particular, down-regulation of
genes in lipid metabolic pathways and consequently re-
duced milk FP has been demonstrated in dairy cows in
response to USFA supplements including LSO [30, 93]
and supported by our data.
Our data show that pathways in cell death and survival
were affected by treatments, more so by LSO (Fig. 5 and
Additional file 15). Controlled cell death in the mam-
mary gland is vital to maintain proper physiological pro-
cesses and functioning. Experimental animals were in
mid-lactation, a period characterized by a decline in milk
production due to a gradual decrease in mammary cell
number with advancing days in lactation. This waning in
cell number is due to continual cell death by apoptosis
which far exceeds the rate of cell renewal [94]. Interest-
ingly, the expression direction (up- or down-regulated)
of several genes (Additional files 16 and 17) in this study
was predicted by IPA to decrease cell death and apop-
tosis. When the rate of mammary cell apoptosis/death is
decreased after peak lactation, it could ensure greater cell
survival and consequently enhanced lactation persistency
and productivity. Some of the implicated genes also have
roles in lipid synthesis/metabolism like, SREBF1, STAT5A/
5B, SCP2, CNTFR, FASN, ADORA2B, CALB1, TRIB3,
F2RL1, PIK3CG and PDK4, thus further emphasizing their
significance in mammary gland growth, development and
productivity. Our data suggest that supplemental feeding
with LSO in addition to enhancing the concentrations of
beneficial FAs in milk could also enhance mammary cell
survival and lactation persistency.
Three canonical pathways (oncostatin signaling, IL-22
signaling and role of JAK family kinases in IL-6-type
cytokine signaling) were significantly enriched by DE
genes of both treatments (day-14 vs day+28). Oncostatin
M (OSM), a member of the IL-6 family of cytokines me-
diates its biological effects by binding to receptors on
leukemia inhibiting factor receptor or OSM receptor-
beta and activation of JAK family members, which in
turn leads to activation of STAT proteins. In this study,
two STAT genes (STAT5A and 5B) and two further
genes (TIMP3 and TYK2) implicated in Oncostatin M
signaling, IL-22 signaling/role of JAK family kinases in IL-
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6-type cytokine signaling (STAT5A and 5B and TYK2)
were significantly down-regulated and predicted by IPA to
down-regulate significantly Oncostatin M (z-score = −2, p-
value = 1.18E-04) and JAK/STAT (z-score = −1, p-value =
2.1E-03) signaling pathways by LSO treatment, thus sug-
gesting the involvement of these pathways in mammary
lipid metabolism.
The liver X receptors/retinoid X receptors (LXRs/
RXRs) pathway was also significantly enriched by DE
genes of both treatments (day+7 and day+28 compared).
LXRs are members of the nuclear receptor superfamily
of transcription factors that regulate the transcription of
several genes involved in cholesterol metabolism [95].
LXR function by activating genes that promote the elim-
ination of/limit the accumulation of cellular cholesterol
when in excess [95]. In this study, eight and five DE
molecules in respectively LSO and SFO treatments were
enriched in this pathway and positive Z-scores (Z-score
= 0.816 for LSO and 1.00 for SFO) which denote activa-
tion, suggest the involvement of this pathway in lipid
metabolism/cholesterol metabolism in dairy cattle.
A huge difference between the two types of supplemen-
tal oils was seen during the first 7 days of supplementation
resulting in DE genes and enriched pathways in LSO but
not for SFO when Day-14 was compared with day+7
(Tables 4, 5 and 7). Six DE genes enriched in the comple-
ment system showed a balance in gene expression (3 up-
regulated [C2, C3 and C1QA] and 3 down-regulated
[CFB, CFI and SERPING1]) which translated to a zero Z-
score implying that the complement system (part of the
innate immune system) was neither activated nor
depressed by LSO treatment. Enrichment of the UDP-N-
acetyl-D-glucosamine Biosynthesis II and UDP-N-acetyl-
D-galactosamine Biosynthesis II biosynthesis pathways
could have contributed to the synthesis of metabolites or
activated pathways that contributed to the difference in
response by cows fed LSO as compared to SFO.
Conclusion
Milk FP was decreased by ~30 % by USFA enriched sup-
plements accompanied by reductions in the concentra-
tions of several SFAs while several USFAs were increased.
LSO modulated the transcriptome of the mammary gland
of dairy cows to a greater extent as compared to SFO by
affecting more genes and pathways. Several DE genes
(FBP2, UCP2, TIEG2, ANGPTL4, ALDH1L2) with ≥2 fold
regulation by both treatments are potential candidate
genes of mammary lipid metabolism. Involvement of some
genes (SCP2, PDK4, NQO1, F2RL1, DBI, CPT1A, CNTFR,
CALB1, ACADVL, SPTLC3, PIK3CG, PIGZ, ADORA2B,
TRIB3, HPGD, IGFBP2 and TXN) in FA/lipid metabolism
in dairy cows is being reported in this study for the first
time. DE genes were enriched in several pathways includ-
ing lipid metabolism and cell death/survival. Several DE
genes were predicted by IPA to significantly decrease the
synthesis of FAs and lipid, and FA metabolism by LSO
treatment and synthesis of FA and lipid metabolism by
SFO. Expression direction of several DE genes in LSO
treatment was predicted to decrease death of mammary
cells and could be managed to achieve enhanced lactation
persistency and productivity.
Finally, this study provides a broader picture of the
transcriptomic events that are involved in mammary
gland adaptation to diets rich in USFAs with indication
that LSO, rich in α-linolenic acid with 3 double bonds,
has a greater impact on mammary gland transcriptome
by affecting more genes, pathways and processes as
compared to SFO, rich in linoleic acid with 2 double
bonds. Our study suggests that decrease in milk SFAs
was due to down-regulation of genes in the FA/lipid
synthesis and lipid metabolism pathways while increase
in PUFAs was due to increased availability of ruminal
biohydrogenation metabolites that were up taken and
incorporated into milk or used as substrate for the syn-
thesis of long chain PUFAs in the mammary gland. Our
study further suggests that DE genes were involved in
similar (lipid metabolism, molecular transport, small
molecule biochemistry) and different (cell death and sur-
vival, protein synthesis, cellular growth and proliferation,
and amino acid metabolism for LSO; and energy pro-
duction, cellular movement, cell cycle and carbohydrate
metabolism for SFO) functions/pathways by the two
types of supplemental ingredients. Moreover, our study
provides further knowledge on mammary lipogenesis
and data that can be used to develop new nutritional
strategies for a better management of milk increased
beneficial FAs.
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